Hackensack Meridian Health’s Vanguard Long-Term Bond ETF BLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-78,647
Closed -$640K 9
2022
Q3
$640K Buy
78,647
+13,647
+21% +$1.08M 0.09% 10
2022
Q2
$5.18M Buy
+65,000
New +$5.35M 0.58% 10

Other funds holding BLV

Hackensack Meridian Health's BLV Position: Q4 2022 in Review

Hackensack Meridian Health sold out of Vanguard Long-Term Bond ETF (BLV) in Q4 2022, closing a stake of 78,647 shares — an estimated $640K sold.

Hackensack Meridian Health first reported a position in BLV in Q2 2022 and held it in 2 quarters. The position peaked at $5.18M in Q2 2022. 269 funds tracked by Wall St. Rank hold BLV as of Q4 2022.

  • Hackensack Meridian Health reported no remaining Vanguard Long-Term Bond ETF position as of Q4 2022 after selling out during the quarter.
  • Hackensack Meridian Health sold 78,647 Vanguard Long-Term Bond ETF shares in Q4 2022, an estimated $640K.
  • Hackensack Meridian Health first reported a position in Vanguard Long-Term Bond ETF in Q2 2022 and held it in 2 quarters.
  • Hackensack Meridian Health's Vanguard Long-Term Bond ETF position peaked at $5.18M in Q2 2022.
  • 269 funds tracked by Wall St. Rank held Vanguard Long-Term Bond ETF as of Q4 2022.

Based on Hackensack Meridian Health's 13F filing for Q4 2022, filed 7 Feb 2023.